Who are Natroba's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Ulesfia, NeutraLice Lotion, Moov Head Lice Solution, NeutraLice Advance Solution, Benzyl Alcohol Lotion 5%, Abametapir Lotion 0.74% w/w.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/spinosad.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Natroba — Competitive Intelligence Brief

Natroba (SPINOSAD) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Pediculicide [EPC]. Area: Neuroscience.

marketed Pediculicide [EPC] Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Natroba (SPINOSAD) — Cipher. Natroba works by activating glutamate-gated chloride channels in the nervous system of lice, leading to an influx of chloride ions and eventual death.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Natroba TARGET	SPINOSAD	Cipher	marketed	Pediculicide [EPC]		2011-01-01
Ulesfia	BENZYL ALCOHOL	Shionogi	marketed	Pediculicide [EPC]		2009-01-01
NeutraLice Lotion	NeutraLice Lotion	Altman Biomedical Consulting Pty. Ltd.	marketed	Pediculicide
Moov Head Lice Solution	Moov Head Lice Solution	Altman Biomedical Consulting Pty. Ltd.	marketed	Pediculicide
NeutraLice Advance Solution	NeutraLice Advance Solution	Altman Biomedical Consulting Pty. Ltd.	marketed	Pediculicide
Benzyl Alcohol Lotion 5%	Benzyl Alcohol Lotion 5%	Akorn, Inc.	phase 3	Pediculicide
Abametapir Lotion 0.74% w/w	Abametapir Lotion 0.74% w/w	Dr. Reddy's Laboratories Limited	phase 3	Metalloproteinase inhibitor (pediculicide)	Lice metalloproteinases (zinc-dependent enzymes)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Pediculicide [EPC] class)

Cipher · 1 drug in this class
Shionogi · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Natroba — Competitive Intelligence Brief. https://druglandscape.com/ci/spinosad. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab